Navigation Links
Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Date:10/29/2009

,724 (6)% 239,141 219,638 9% Adjusted Diluted EPS $0.63 $0.66 (5)% $2.04 $1.74 17%

"This is an exciting time for Endo Pharmaceuticals," said Dave Holveck, president and CEO of Endo. "Our core business continues to exceed our expectations; we have successfully launched Valstar(TM) for bladder cancer this quarter, and we are planning for the launch of our long-acting injectable testosterone product, which will now be called Aveed(TM). We believe our third quarter performance, in conjunction with a solid outlook for the remainder of the year, warrants an increase in our revenue and earnings guidance. And we continue to actively pursue business development opportunities that will further diversify our top line in the years ahead."

2009 Financial Guidance

The company is raising guidance for 2009 annual total revenues and adjusted diluted earnings per share. The company now estimates total revenues to be between $1.440 billion and $1.465 billion. The company also now estimates reported (GAAP) diluted earnings per share to be between $1.41 and $1.47, and this EPS increase is primarily due to changes in the fair value of contingent consideration associated with the Indevus transaction partially offset by the addition of milestone payments associated with the company's recent deal with ProStrakan to in-license FORTESTA(TM). Adjusted diluted earnings per share are now estimated to be between $2.67 and $2.73. The company's reported (GAAP) EPS guidance does not include any estimates for potential future changes in the fair value of contingent consideration or for potential new business development transactions. These items could have a significant impact on the actual reported diluted earnings per share in the future. A reconciliation of GAAP to non-GAAP calculations is attached to this press release.

Third Quarter Highlights

On Septembe
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
2. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
4. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
5. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
6. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
7. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
8. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
9. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
10. BioMarin Acquires Huxley Pharmaceuticals, Inc.
11. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... -- A drug commonly taken to prevent seizures in epilepsy ... (MS), according to a study released today that will be ... in Washington, DC , April 18 to ... MS experience at some point in their life a condition ... from the eye to the brain gets inflamed," said study ...
(Date:4/16/2015)... , April 16, 2015  Alexza Pharmaceuticals, Inc. (Nasdaq: ... ended March 31, 2015 on Wednesday, May 6, 2015, following ... also host an investor conference call and live webcast on ... a company update and discuss the financial results.  ... www.alexza.com , under the "Investors" link.  Please log onto ...
(Date:4/16/2015)... DUBLIN , April 16, 2015 ... specialty biopharmaceutical company, today announced that it has ... purchase price of approximately $2.3 billion. The Ikaria ... and expands its reach into neonatal critical care ... vital treatment option for a highly vulnerable patient ...
Breaking Medicine Technology:Epilepsy Drug May Preserve Eyesight for People with MS 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5
... Jan. 11, 2011 Reportlinker.com announces that a ... catalogue: Johnson & Johnson: PharmaVitae ... IntroductionThis analysis examines the historical ... the prescription pharmaceutical sector. The profile encompasses global ...
... Reportlinker.com announces that a new market research ... Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile ... IntroductionThis analysis examines the historical ... pharmaceutical sector. The profile encompasses global company strategy, ...
Cached Medicine Technology:Reportlinker Adds Johnson & Johnson: PharmaVitae Profile 2Reportlinker Adds Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile 2
(Date:4/17/2015)... York, NY (PRWEB) April 18, 2015 ... at their facility, rounding out their list of diagnostic ... care center for patients on the Upper East Side ... and running at full capacity. The addition of PET-CT, ... gives their physicians the ability to work with patients ...
(Date:4/17/2015)... Tampa, Florida (PRWEB) April 17, 2015 ... Term Acute Care and Florida Hospital Carrollwood were all ... Hospital Wesley Chapel, located in Pasco County, is ranked ... Bay Times workplaces survey, which was conducted in partnership ... is an 83 all-private bed hospital that opened in ...
(Date:4/17/2015)... San Jose, CA (PRWEB) April 17, 2015 ... of life insurance protection without modifications can now use ... are now general life insurance policy rates that are ... . , The standard plans that are offered are ... for adults aged 18 to 79. There are now ...
(Date:4/17/2015)... 17, 2015 At the end of ... and the “Salute to the Oscars” in the Stardust ... Hotel, overlooking the impressive Los Angeles skyline. These events ... Debbie Durkin, LA’s leading producer of sustainable product placement ... the world’s premier providers of eco-friendly and socially conscious ...
(Date:4/17/2015)... Organic Valley, the nation’s largest cooperative ... International Year of Soils by “Cycling for Sustainability” through ... employees will travel 215 miles from Auburn, California, to ... about the impact of agriculture on water and soil ... Maine, Wisconsin, Oregon, and Washington state, the cyclists have ...
Breaking Medicine News(10 mins):Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 3
... Choice Act, Spark Major Drive for Healthcare Union Organizing, ... Calif. and WASHINGTON, March 19 In ... pass the Employee Free Choice Act and rapidly promote ... International Union and the California Nurses Association/National ...
... Health Provisions , ... Newport Beach, CA. (PRWEB) March ... benefits management services , today released a summary of the ... face of the significant changes from Barack Obama’s new administration, Secova ...
... and homeopathic alternative for reducing the symptoms related ... (ADHD) without a prescription and without negative side ... medication use in children ages 5 to 19 ... researchers from the Saint Louis University School of ...
... March 19 The 2009 Frost & ... Product Quality Leadership Award is presented to ... Uncompromising quality maintenance, together with exceptional customer ... success. (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... is National Brain Injury Awareness MonthWHEATON, Ill., March 18 ... 3.8 million individuals in the U.S. each year according to ... a type of traumatic brain injury (TBI) caused by a ... mild to severe. It is important to note that even ...
... playsPHOENIX, March 18 Gold Canyon, a leader ... Candle Game to benefit the Prayer Child Foundation. For every ... will donate 10 cents to help children facing physical and ... http://thecandlegame.com and through Facebook on Gold Canyon,s official ...
Cached Medicine News:Health News:SEIU, CNA/NNOC Announce Major Accord 2Health News:SEIU, CNA/NNOC Announce Major Accord 3Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 3Health News:ADD-care -- A Natural, Homeopathic Alternative Reducing Symptoms Related to Attention Deficit Disorder 2Health News:ADD-care -- A Natural, Homeopathic Alternative Reducing Symptoms Related to Attention Deficit Disorder 3Health News:Frost & Sullivan Product Quality Accolade for KIBI Software Solutions 2Health News:Frost & Sullivan Product Quality Accolade for KIBI Software Solutions 3Health News:Sports Concussions: Common and Preventable 2Health News:Gold Canyon Ignites Hope With Online Charity Candle Game 2
Adjustable speed vortex with inter-changeable heads , 110 V...
Inquire...
Adjustable speed vortex with inter-changeable heads, 110 V...
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
Medicine Products: